Net profit of Jagsonpal Pharmaceuticals rose 9.69% to Rs 12.57 crore in the quarter ended September 2025 as against Rs 11.46 crore during the previous quarter ended September 2024. Sales declined 0.29% to Rs 74.47 crore in the quarter ended September 2025 as against Rs 74.69 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended |
| Sep. 2025 | Sep. 2024 | % Var. |
| Sales | 74.47 | 74.69 | 0 |
| OPM % | 22.08 | 21.81 | - |
| PBDT | 19.20 | 17.71 | 8 |
| PBT | 16.81 | 15.37 | 9 |
| NP | 12.57 | 11.46 | 10 |